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EditorialCredibility and ReproducibilityCredibility is everything for science, and it is built over time in
both obvious and subtle ways. It is how we interact with col-
leagues and collaborators. It is how generously and openly we
share reagents and how we mentor students and postdocs. It
is how we review each other’s papers, and it is how we credit
others’ work. It is the way we educate and inform the public
that funds us. It is the way we document and store our data.
And it is the rigor, transparency, and attention we invest in
designing, conducting, and reporting experiments. Without
credibility, others can’t/won’t build on our work, and as a result,
the pace of scientific advance is slowed. Most importantly, sci-
ence contaminated with a lack of credibility is a housewith crum-
bling walls that engenders little trust and provides minimal value
to our global society, present and future.
But everyone reading this already knows the importance of
credibility in science, so why are we discussing it here? Within
the last 12 months the reproducibility of science, a lynchpin of
credibility, has come under intense scrutiny, both from the NIH
(Nature 505, 612–613) and other government funding bodies,
as well as in the lay (The Economist, October 19, 2013, 23–28)
and scientific press (Nature 483, 531–533—though many of
these reports themselves would benefit from greater transpar-
ency in reporting and still require robust demonstrations of
reproducibility). Hearing the word ‘‘reproducibility,’’ most of us
think immediately of fraud or data and image manipulation, but
it is much broader than that. Many of the current concerns about
reproducibility, particularly the successful scalability of preclini-
cal data into robust drug targets for treating human disease, are
focused on the rigor of the experimental design (inclusion of all
appropriate controls, blinded experimental conditions, gender
balance in experimental populations, a priori determination of
n’s and statistical power, appropriate statistical analyses, etc.)
and on complete transparency in reporting of these parameters
and all collected data (for a recent Perspective on this topic, see
Neuron 84, 572–581.)
In June of this year Francis Collins, NIH Director, Marcia
McNutt, Editor-in-Chief of Science, and Philip Campbell, Edi-
tor-in-Chief of Nature, organized a meeting of journal editors
and other contributors to collaborate on approaches to ensuring
and improving reproducibility. Maximizing reproducibility clearly
is an initiative involving many stakeholders, with scientists front
and center and funding bodies, universities, journals, pharma-
ceutical and biotech companies, patient advocacy groups,
and society at large all taking a leading role as well. Out of the
discussions at this meeting came a set of recommendations
for how journals and journal editors can do their part. The
main focus of the guidelines is to ensure rigorous experimental
design and transparency in reporting the specifics about how
experiments were performed and how data were collected
and analyzed. Cell Press participated in the meeting and is a sig-
natory on the recommendations that were recently posted
(http://www.nih.gov/about/reporting-preclinical-research.htm).
Many of the items in the guidelines Cell and its sister journals are
already doing and have been doing for quite some timeRe(providing space for lengthy methods sections in print and un-
limited supplemental methods online, requiring the sharing of
reagents as a condition of publication, providing a forum for
refutation in our Matters Arising format, requiring authors to
clearly state their statistical measures.) Other items in the guide-
lines, like developing a way to facilitate clear reporting in the
paper of details about how experiments were designed and per-
formed, will be valuable additions to what we already do. Jour-
nals are encouraged to adopt a checklist of specific reporting
criteria as a standard form for authors to complete and editors
and/or reviewers to verify. While we at Cell and the other Cell
Press journals are not yet sure that an author checklist per se
will be the most effective implementation for our authors, re-
viewers, and readers, we do wholly embrace the importance
of the goals of the guidelines and will be taking steps to adapt
our editorial processes and author instructions to ensure consis-
tent standards for appropriate experimental design and trans-
parency in reporting. For example, Developmental Cell has
recently introduced supplemental protocols, where authors of
a paper with noteworthy, new, or particularly challenging
methods are encouraged to provide a detailed protocol in a
separate supplemental PDF. We view these steps as an impor-
tant part of the value that we add through the editorial and peer
review process.
Enhanced attention to these elements will also help protect
the authors’ credibility. With increased clarity about how exper-
iments were performed and collected, editors, authors, and re-
viewers will all be better able to spot and rectify concerns before
the paper is published, hopefully reducing the number of cor-
rections and retractions required postpublication. To this end,
Cell and our sister journals are also introducing an image
screening process to help ensure adherence to community
standards as outlined in our data processing policies. More
and more, we are finding that the concerns that arise regarding
published data are often the result of avoidable errors. For
example, copying and pasting the same image into two different
figures or failing to indicate where lanes of a gel have been
spliced together. (Oddly, the most pervasive challenges to pub-
lished data we see at Cell relate to loading controls. There
seems to be some misalignment among scientists regarding
the importance and meaning of the actin bands in a standard
western blot.) When potential problems are brought to our
attention by a concerned reader, we ask the authors to provide
us with the original unprocessed data, together with a detailed
explanation of how they conducted the experiment. Most of
the time, we can see from the raw data that the problems
have been introduced through simple mistakes and can be ad-
dressed with an erratum. But a scientific literature peppered
with corrections does not build credibility, and worse still is
when the avoidable errors are sufficiently extensive that they
undermine the reliability of the entire body of work and necessi-
tate a retraction. So, as we at Cell invest in checking figures and
working with authors to fix any correctable mistakes before the
paper is published, we ask that authors renew their focus onprinted from Cell 159, November 20, 2014 ª2014 Elsevier Inc. 383
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Editorialpreparing their manuscripts and reviewing the final figures with
the same attentive eyes their readers will. By combining
enhanced clarity of reporting as recommended by the new
guidelines with prepublication image screening, our intent is to
ensure that every paper we publish meets not only the highest
standards of interest and importance but also of credibility
and reproducibility.384 Reprinted from Cell 159, November 20, 2014 ª2014 Elsevier IncWith increased vigilance from authors, funders, and journals
and attention to standards for experimental design and accurate
careful reporting, wewill collectively increase the public trust and
support for research and build a stronger pipeline for converting
our understanding of the basic processes and mechanisms of
biology into improved diagnostics, treatments, and potentially
cures for the myriad of global health challenges.Emilie Marcus
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